Recent news

New Centre for Medicines Research (CMR) Clinical Factbook From Clarivate Highlights Increasing Cost and Complexity of Phase II Trials

Pharmaceutical clinical industry report highlights factors impacting volume, cost and duration of Phase II trials LONDON, Nov. 24, 2020 /PRNewswire...

Clarivate Expands International Real-World Data Offering with Addition of Techtrials Brazilian Dataset

Partnership to provide life science, healthcare and research professionals with comprehensive RWD capturing approximately 80% of the Brazilian...

Cloud Gaming Positioned for Strong Future Growth According to New Research From Clarivate

Clarivate Plc (NYSE: CCC), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released a new...

Taking the Pulse® 2020 Physician Survey Shows 4 in 5 U.S. Physicians Have Conducted Virtual Patient Consults Amid the COVID-19 Pandemic

Taking the Pulse® 2020 Physician Survey Shows 4 in 5 U.S. Physicians Have Conducted Virtual Patient Consults Amid the COVID-19 Pandemic New...

Clarivate Analytics

Clarivate Launches Coronavirus, Virology, and Infectious Disease (CVID) Data Lake to Accelerate Research, Preparedness and Response to Future...

Clarivate Analytics Closes Acquisition of Decision Resources Group

Decision Resources Group Announced as HIDA Industry Data Program Partner

Decision Resources Group (DRG), www.decisionresourcesgroup.com, a premier provider of high-value healthcare data, analytics, and insights products...

Decision Resources Group Announced as HIDA Industry Data Program Partner

OUTSOURCED PHARMA

What Will the USMCA Mean for MedTech?

MedCityNews

Outcome-based contracts likely to keep growing, evolving despite challenges

PM360

A New Era in Point of Care Marketing

Cell & gene

CAR T-Cell Therapy In Non-Hodgkin's Lymphoma: Where Do We Go From Here?